Karin Eastham sold $506K of Veracyte (VCYT)

Executed Nov 19 2024, disclosed Nov 21 2024, 2 days later.

Value, as filed

$506K

13,131 sh across 2 lots

Executed

Nov 19 2024

the trade date, as filed

Disclosed

Nov 21 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Karin Eastham Director profile →

Karin Eastham (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $872K of VCYT (19,200 sh across 2 lots, as filed), executed Dec 5 2025.

The name

VCYT

Veracyte, Inc. VCYT · Healthcare · 50 filings in 24 months ticker →

Healthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Karin Eastham in VCYT

VCYTSALE Veracyte, Inc. $743K
14,850 sh × $50.00
Exec Oct 27
Filed Oct 28 · 4:05 PM ET VCYTSALE Veracyte, Inc. $169K
3,200 sh × $52.78
Exec Jun 18
Filed Jun 22 · 5:30 PM ET VCYTSALE Veracyte, Inc. $872K
19,200 sh across 2 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $387K
9,674 sh × $40.02
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $122K
4,590 sh × $26.66
Exec Jun 13 2025
Filed Jun 17 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $403K
10,000 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET